natgillin/translations-raw huggingface dataset:
road users, including vulnerable users (e.g. pedestrians, cyclists, motorcyclists);
uporabniki cest, vključno z ranljivimi uporabniki (npr. pešci, kolesarji in motoristi);
traffic (e.g. traffic volume, traffic categorisation by type);
promet (npr. obseg prometa, razvrščanje prometa po kategorijah glede na vrsto);
seasonal and climatic conditions;
letni čas in podnebne razmere;
presence of a sufficient number of safe parking areas;
obstoj zadostnega števila parkirišč;
seismic activity.
potresna aktivnost.
ROAD SAFETY AUDITS FOR INFRASTRUCTURE PROJECTS
PREVERJANJE VARNOSTI V CESTNEM PROMETU V ZVEZI Z INFRASTRUKTURNIMI PROJEKTI
Criteria at the draft design stage:
Merila v fazi idejnega projekta:
geographical location (e.g. exposure to landslides, flooding, avalanches), seasonal and climatic conditions and seismic activity;
zemljepisna lega (npr. izpostavljenost zemeljskim plazovom, poplavam, snežnim plazovom), pogoji glede na letni čas, podnebne razmere in potresna aktivnost;
types of and distance between junctions;
vrste križišč in razdalje med njimi;
number and type of lanes;
število in vrste voznih pasov;
kinds of traffic admissible to the new road;
vrste prometa, dovoljenega za novo cesto;
functionality of the road in the network;
funkcionalnost ceste v omrežju;
meteorological conditions;
meteoroloških pogojev;
driving speeds;
hitrost vožnje;
cross-sections (e.g. width of carriageway, cycle tracks, foot paths);
prečni prerezi (npr. širina cestišč, kolesarskih stez, stez za pešce);
horizontal and vertical alignments;
vodoravne in navpične trase;
junctions layout;
ureditev križišč;
public transport and infrastructures;
javna prevozna sredstva in infrastruktura;
road/rail level crossings.
cestni/železniški nivojski prehodi.
Criteria for the detailed design stage:
Merila v fazi podrobnega načrta:
layout;
ureditev;
coherent road signs and markings;
usklajeni prometni znaki in označbe;
lighting of lit roads and intersections;
osvetlitev razsvetljenih cest in križišč;
roadside equipment;
oprema ob cestah;
roadside environment including vegetation;
okolje ob cesti, vključno z vegetacijo;
fixed obstacles at the roadside;
nepremične ovire ob cesti;
provision of safe parking areas;
zagotovitev varnih parkirišč;
vulnerable road users (e.g. pedestrians, cyclists, motorcyclists);
ranljivi uporabniki (npr. pešci, kolesarji, motoristi);
user-friendly adaptation of road restraint systems (central reservations and crash barriers to prevent hazards to vulnerable users).
uporabniku prijazna prilagoditev varovalnih ograj (srednjih ločilnih pasov in odbojnih ograj za preprečevanje tveganj pri ranljivih uporabnikih).
Criteria for the pre-opening stage:
Merila v fazi pred odprtjem:
safety of road users and visibility under different conditions such as darkness and under normal weather conditions;
varnost udeležencev v cestnem prometu in vidljivost v različnih razmerah, na primer ponoči in v običajnih vremenskih razmerah;
readability of road signs and markings;
čitljivost prometnih znakov in označb;
condition of pavements.
stanje cestišča.
Criteria for early operation: assessment of road safety in the light of actual behaviour of users.
Merila za začetno delovanje: ocena varnosti v cestnem prometu z vidika dejanskega vedenja uporabnikov.
Audits at any stage may involve the need to reconsider criteria from previous stages.
Preverjanja v vseh fazah lahko vključujejo potrebo po ponovni preučitvi meril iz prejšnjih faz.
RANKING OF HIGH ACCIDENT CONCENTRATION SECTIONS AND NETWORK SAFETY RANKING
RAZVRŠČANJE CESTNIH ODSEKOV GLEDE NA ŠTEVILO NESREČ IN RAZVRŠČANJE VARNOSTI OMREŽJA
Identification of road sections with a high accident concentration
Določitev cestnih odsekov, kjer se zgodi veliko nesreč
The identification of road sections with a high accident concentration takes into account at least the number of fatal accidents that have occurred in previous years per unit of road length in relation to the volume of traffic and, in case of intersections, the number of such accidents per location of intersections.
Določitev cestnih odsekov, kjer se zgodi veliko nesreč, upošteva najmanj število nesreč s smrtnim izidom, ki so se zgodile v prejšnjih letih na enoto dolžine ceste glede na obseg prometa in v primeru križišč število takšnih nesreč na lokacijo križišč.
Identification of sections for analysis in network safety ranking
Določitev odsekov za analizo v okviru razvrščanje varnosti omrežja
The identification of sections for analysis in network safety ranking takes into account their potential savings in accident costs.
Pri določitvi odsekov za analizo v okviru razvrščanje varnosti omrežja se upošteva njihov potencial prihranka stroškov nesreč.
Road sections shall be classified into categories.
Cestni odseki se razvrstijo po kategorijah.
For each category of roads, road sections shall be analysed and ranked according to safety-related factors, such as accidents concentration, traffic volume and traffic typology.
Za vsako kategorijo cest se cestni odseki analizirajo in razvrstijo glede na dejavnike v zvezi z varnostjo, kot so število nesreč, obseg prometa in vrsta prometa.
For each road category, network safety ranking shall result in a priority list of road sections where an improvement of the infrastructure is expected to be highly effective.
V okviru razvrščanje varnosti omrežja se za vsako kategorijo cest določi prednostni seznam cestnih odsekov, za katere se predvideva, da bo izboljšava infrastrukture dosegla visok učinek.
Elements of evaluation for expert teams’ site visits:
Elementi ocenjevanja pri obiskih skupine strokovnjakov na terenu:
a description of the road section;
opis cestnega odseka;
a reference to possible previous reports on the same road section;
sklic na morebitna prejšnja poročila o istem cestnem odseku;
the analysis of possible accident reports;
analiza morebitnih poročil o nesreči;
the number of accidents, of fatalities and of severely injured persons in the three previous years;
število smrtnih žrtev nesreč in huje poškodovanih oseb v zadnjih treh letih;
a set of potential remedial measures for realisation within different timescales considering for example:
nabor možnih popravnih ukrepov za realizacijo v roku različnih časovnih okvirov ob upoštevanju npr.:
removing or protecting fixed roadside obstacles,
odstranjevanja ali zavarovanja nepremičnih ovir ob cesti,
reducing speed limits and intensifying local speed enforcement,
zmanjševanja omejitev hitrosti in poostritve lokalnega uveljavljanja omejitev hitrosti,
improving visibility under different weather and light conditions,
izboljševanja vidljivosti v različnih vremenskih in svetlobnih razmerah,
improving safety condition of roadside equipment such as road restraint systems,
izboljševanja varnostnega stanja opreme ob cesti, kot so varovalne ograje,
improving coherence, visibility, readability and position of road markings (incl. application of rumble strips), signs and signals,
izboljševanja usklajenosti, vidljivosti, čitljivosti in položaja cestnih oznak (vključno z uporabo opozorilnih črt), prometnih znakov in signalizacije,
protecting against rocks falling, landslips and avalanches,
zaščite pred padajočim kamenjem, zemeljskimi in snežnimi plazovi,
improving grip/roughness of pavements,
izboljševanja oprijema/hrapavosti cestišča,
redesigning road restraint systems,
drugačnega načrtovanja varovalnih ograj,
providing and improving median protection,
postavljanja in izboljšav odbojnih ograj na sredini,
changing the overtaking layout,
spreminjanja ureditve prehitevalnega pasu,
improving junctions, including road/rail level crossings,
izboljševanja križišč, vključno s cestnimi/železniškimi nivojskimi prehodi,
changing the alignment,
spreminjanja trase,
changing width of road, adding hard shoulders,
spreminjanja širine ceste, dodajanja utrjenih bankin,
installing traffic management and control systems,
namestitve sistemov za upravljanje prometa in sistemov nadzora,
reducing potential conflict with vulnerable road users,
zmanjševanja možnosti spora z ranljivimi uporabniki cest,
upgrading the road to current design standards,
nadgradnje ceste ob upoštevanju trenutnih konstrukcijskih standardov,
restoring or replacing pavements,
obnove ali zamenjave vrhnje plasti cestišč,
using intelligent road signs,
uporabe inteligentnih prometnih znakov,
improving intelligent transport systems and telematics services for interoperability, emergency and signage purposes.
izboljšanja inteligentnih prometnih sistemov in telematskih storitev za interoperabilne, reševalne ali signalne namene.
ACCIDENT INFORMATION CONTAINED IN ACCIDENT REPORTS
INFORMACIJE O NESREČAH V POROČILIH O NESREČAH
Accident reports include the following elements:
Poročilo o nesreči vključuje naslednje elemente:
precise as possible location of the accident;
kar se da natančno navedbo kraja nesreče;
pictures and/or diagrams of the accident site;
slike in/ali oris mesta nesreče;
date and hour of accident;
datum in uro nesreče;
information on the road such as area type, road type, junction type incl. signalling, number of lanes, markings, road surface, lighting and weather conditions, speed limit, roadside obstacles;
podatke o cesti, kot so vrsta območja, vrsta ceste, vrsta križišča, vključno s signalizacijo, številom voznih pasov, oznakami, vrhnjo plastjo cestišča, osvetlitvijo in vremenskimi razmerami, omejitvijo hitrosti, ovirah ob cesti;
accident severity, including number of fatalities and injured persons, if possible according to common criteria to be defined in accordance with the regulatory procedure with scrutiny referred to in Article 13(3);
resnost nesreče, vključno s številom smrtnih žrtev in poškodovanih, če je mogoče po skupnih merilih, ki jih je treba določiti v skladu z regulativnim postopkom s pregledom iz člena 13(3);
characteristics of the persons involved such as age, sex, nationality, alcohol level, use of safety equipment or not;
podatki o udeleženih osebah, na primer starost, spol, državljanstvo, raven alkohola v krvi, uporaba ali neuporaba varnostne opreme;
data on the vehicles involved (type, age, country, safety equipment if any, date of last periodical technical check according to applicable legislation);
podatki o udeleženih vozilih (vrsta, starost, država, morebitna varnostna oprema), datum zadnjega rednega tehničnega pregleda v skladu z veljavno zakonodajo);
accident data such as accident type, collision type, vehicle and driver manoeuvre;
podatki o nesreči, na primer vrsta nesreče, vrsta trčenja, obnašanje vozila in voznika;
whenever possible, information on the time elapsed between the time of the accident and the recording of the accident, or the arrival of the emergency services.
kadar je mogoče, informacije o času, ki je potekel med časom nesreče in njenim zabeleženjem ali prihodom reševalne službe.
Directive 2008/97/EC of the European Parliament and of the Council
Direktiva 2008/97/ES Evropskega parlamenta in Sveta
amending Council Directive 96/22/EC concerning the prohibition on the use in stockfarming of certain substances having a hormonal or thyrostatic action and of beta-agonists
o spremembi Direktive Sveta 96/22/ES o prepovedi uporabe v živinoreji določenih snovi, ki imajo hormonalno ali tirostatično delovanje, in beta-agonistov
Article 2 of Directive 96/22/EC [3] prohibits, inter alia, the placing on the market of stilbenes, stilbene derivatives, their salts and esters and thyrostatic substances for administering to animals of all species.
Člen 2 Direktive 96/22/ES [3] med drugim prepoveduje dajanje na trg stilbenov, derivatov stilbenov, njihovih soli in estrov ter tirostatičnih snovi za dajanje živalim vseh vrst.
The reason for that absolute prohibition was that potential abuse or misuse would be more difficult if there were no product authorised for any animal species whatsoever on the market.
Razlog za to popolno prepoved je bil, da bi težje prišlo do morebitne nepravilne uporabe ali zlorabe, če na trgu ne bi bilo nobenega proizvoda, dovoljenega za katero koli živalsko vrsto.
However, experience gained in particular with national residue plans submitted under Council Directive 96/23/EC of 29 April 1996 on measures to monitor certain substances and residues thereof in live animals and animal products [4] has shown that the misuse of product presentations intended for pet animals does not play a role as a source of abuse or misuse.
Vendar so izkušnje, ki izhajajo zlasti iz nacionalnih načrtov o ostankih škodljivih snovi, predloženih v skladu z Direktivo Sveta 96/23/ES z dne 29. aprila 1996 o ukrepih za spremljanje nekaterih snovi in njihovih ostankov v živih živalih in v živalskih proizvodih [4], pokazale, da zloraba vrst proizvodov, namenjenih za hišne živali, pri nepravilni uporabi ali zlorabi ne igra pomembne vloge.
That is partly because it is economically unattractive to use presentations intended for pet animals for growth promotion in food-producing animals.
Razlog za to je deloma v neekonomičnosti uporabe vrst proizvodov za hišne živali za spodbujanje rasti za živali za proizvodnjo živil.
Moreover, the prohibition of thyrostatic substances has harmful consequences for the welfare of pet animals (dogs and cats) due to the lack of an alternative treatment for hyperthyroidism in those animals.
Poleg tega ima prepoved tirostatičnih snovi zaradi pomanjkanja alternativnih vrst zdravljenja hipertiroze pri hišnih živalih (psi in mačke) škodljive posledice za njihovo dobro počutje.
The Protocol on protection and welfare of animals annexed to the Treaty provides that the Community and the Member States are to pay full regard to the welfare requirements of animals in the implementation of Community policies, in particular with regard to the internal market.
Protokol o zaščiti in dobrem počutju živali, ki je priložen Pogodbi, predvideva, da Skupnost in države članice pri izvajanju politik, zlasti v zvezi z notranjim trgom, v celoti upoštevajo zahteve po dobrem počutju živali.
It is therefore appropriate to limit the scope of Directive 96/22/EC only to food-producing animals and withdraw the prohibition for pet animals, as well as to adjust the definition of therapeutic treatment.
Zato je primerno, da se področje uporabe Direktive 96/23/ES omeji samo na živali za proizvodnjo živil, umakne pa se prepoved za hišne živali in prilagodi opredelitev pojma zdravljenja.
The Opinion of the Scientific Committee on Veterinary Measures relating to Public Health (SCVPH) of 30 April 1999 on the potential risks to human health from hormone residues in bovine meat and meat products (which was reviewed on 3 May 2000 and confirmed on 10 April 2002) concluded that there is a substantial body of recent evidence suggesting that oestradiol 17ß has to be considered as a complete carcinogen, as it exerts both tumour-initiating and tumour-promoting effects, and that the data currently available do not make it possible to give a quantitative estimate of the risk to human health.
Znanstveni odbor za veterinarske ukrepe v zvezi z javnim zdravstvom (SCVPH) je v svojem mnenju z dne 30. aprila 1999 o mogočih tveganjih, povezanih z ostanki hormonov v govejem mesu in mesnih izdelkih, za zdravje ljudi (ponovno pregledano 3. maja 2000 in potrjeno 10. aprila 2002) ugotovil, da obsežni najnovejši dokazi potrjujejo, da je treba estradiol 17β šteti za popolnega karcinogena, ker ima tako učinke povzročanja tumorjev kot pospeševanja rasti tumorjev, in da na podlagi trenutno razpoložljivih podatkov ni mogoče izdelati kvantitativne ocene tveganja za zdravje ljudi.
As a result, Directive 96/22/EC was amended by Directive 2003/74/EC so as to, inter alia, prohibit permanently the use of oestradiol 17β as a growth promoter and reduce substantively all other circumstances in which it can be administered to all farm animals for therapeutic or zootechnical purposes pending further examination of the factual and scientific situation and the veterinary practices in the Member States.
Na podlagi tega je bila Direktiva 96/22/ES spremenjena z Direktivo 2003/74/ES, ki je med drugim do zaključka nadaljnjih preiskav dejanskih in znanstvenih dejstev ter veterinarskih praks v državah članicah trajno prepovedala uporabo estradiola 17β kot pospeševalca rasti in znatno omejila vse ostale okoliščine v katerih se ga lahko uporablja za terapevtske ali zootehnične namene pri domačih živalih.
Article 11a of Directive 96/22/EC required the Commission to present a report by 14 October 2005 concerning the availability of alternative veterinary medicinal products to those containing oestradiol 17β for food-producing animals for therapeutic purposes.
Člen 11a Direktive 96/22/ES je zahteval, da Komisija do 14. oktobra 2005 predloži poročilo o dostopnosti zdravil za uporabo v veterinarski medicini, ki so alternativa tistim, ki vsebujejo estradiol 17β, za živali za proizvodnjo živil za terapevtske namene.
The Commission sought expert advice and established the relevant scientific report, which was forwarded to the European Parliament and the Council on 11 October 2005.
Komisija je pridobila strokovno mnenje in pripravila ustrezno znanstveno poročilo, ki je bilo 11. oktobra 2005 posredovano Evropskemu parlamentu in Svetu.
That Report concludes that oestradiol 17β is not essential in the production of food-producing animals because the use of the available alternatives (especially prostaglandins) by practising veterinarians is already quite common in the Member States and that the complete prohibition of the use of oestradiol 17β for food-producing animals would have no, or only a negligible, impact on farming and animal welfare.
To poročilo ugotavlja, da estradiol 17β za živali za proizvodnjo živil ni nujen, ker je uporaba dostopnih alternativnih načinov zdravljenja (zlasti prostaglandini) med veterinarji praktiki v državah članicah že precej običajna in ker popolna prepoved uporabe estradiola 17β za živali za proizvodnjo živil ne bi imela vpliva na kmetijsko dejavnost in dobro počutje živali, ali bi bil ta zanemarljiv.
Proper compliance with the relevant legislation and the elimination of inappropriate use of unauthorised substances can be enhanced by means of objective information and awareness campaigns.
Z objektivni kampanjami informiranja in osveščanja se lahko poveča ustrezna skladnost z zadevno zakonodajo in prenehanje neustrezne uporabe nedovoljenih snovi.
A temporary exemption was provided for the use of oestradiol 17β for oestrus induction in cattle, horses, sheep or goats until 14 October 2006.
Začasna izjema je bila predvidena za uporabo estradiola 17β za indukcijo estrusa pri govedu, konjih, ovcah ali kozah do 14. oktobra 2006.
Since effective alternative products exist and are already used, and in order to ensure the high level of health protection chosen in the Community, that exemption should not be renewed.
Ker učinkoviti alternativni izdelki že obstajajo in se tudi uporabljajo ter da se v Skupnosti zagotovi izbrana visoka raven zdravstvene zaščite, te izjeme ni treba obnoviti.
Directive 96/22/EC should therefore be amended accordingly,
Zato bi bilo treba Direktivo 96/22/ES ustrezno spremeniti –
Directive 96/22/EC is hereby amended as follows:
Direktiva 96/22/ES se spremeni:
In Article 1(2), point (b) shall be replaced by the following:
V členu 1(2) se točka (b) nadomesti z naslednjim:
“therapeutic treatment” shall mean the administering — under Article 4 of this Directive — to an individual farm animal of an authorised substance to treat, after examination by a veterinarian, a fertility problem — including the termination of unwanted gestation — and, in the case of beta-agonists, to induce tocolysis in cows when calving as well as to treat respiratory problems, navicular disease and laminitis and to induce tocolysis in equidae;’.
‚zdravljenje‘ pomeni dajanje – v skladu s členom 4 te direktive – dovoljene snovi posamezni živali na kmetiji za zdravljenje plodnostne motnje, vključno s prekinitvijo nezaželene brejosti, po veterinarskem pregledu in, v primeru beta-agonistov, za sprožanje tokolize pri kravah med telitvijo, pa tudi za zdravljenje težav z dihanjem, bolezni zakopitnice (navikularnega sindroma) in vnetja kopit (laminitisa) ter za sprožanje tokolize pri kopitarjih;”.
Member States shall prohibit the placing on the market of the substances listed in Annex II for administering to any animals, the meat and products of which are intended for human consumption, for purposes other than those provided for in point 2 of Article 4.’.
Države članice prepovejo dajanje na trg snovi, navedenih v Prilogi II, za vse živali, katerih meso in proizvodi so namenjeni prehrani ljudi, za namene, različne od tistih, predvidenih v točki 2 člena 4.“
In Article 4, point 2(i) shall be replaced by the following:
V členu 4 se točka 2(i) nadomesti z naslednjim:
allyl trenbolone, administered orally, or beta-agonists to equidae, provided they are used in accordance with the manufacturer’s instructions;’.
alil trenbolon za peroralno uporabo ali beta-agoniste kopitarjem, če se uporabljajo v skladu z navodili proizvajalca;“.
Article 5a shall be deleted.
Člen 5a se črta.
In Articles 3, 6, 7, 8, 11 and 14 a, the references to Article 5a shall be deleted.
V členih 3, 6, 7, 8, 11 in 14a se črtajo sklicevanja na člen 5a.
Third countries whose legislation authorises the placing on the market and administration of stilbenes, stilbene derivatives, their salts and esters, or of thyrostatic substances for administering to all species of animals the meat and products of which are intended for human consumption may not appear on any of the lists of countries provided for under Community legislation from which Member States are authorised to import farm or aquaculture animals or meat or products obtained from such animals.’.
Tretje države, katerih zakonodaja dovoljuje promet in uporabo stilbenov, derivatov stilbenov, njihovih soli in estrov, ali tirostatičnih snovi za uporabo pri vseh živalskih vrstah, katerih meso in proizvodi so namenjeni prehrani ljudi, ne smejo biti na seznamih držav, iz katerih smejo v skladu z zakonodajo Skupnosti države članice uvažati živali s kmetij ali živali iz ribogojstva ali meso in proizvode, pridobljene od takih živali.“
Article 11a shall be replaced by the following:
Člen 11a se nadomesti z naslednjim:
With regard to the substances listed in Annex III, the Commission shall seek additional information, taking into account recent scientific data from all possible sources, and keep the measures applied under regular review with a view to the timely presentation to the European Parliament and to the Council of any necessary proposals.’.
Glede snovi, navedenih v Prilogi III, bo Komisija zbrala dodatne informacije, ob upoštevanju najnovejših znanstvenih podatkov iz vseh mogočih virov, in uporabljene ukrepe redno pregledovala, da bo Evropskemu parlamentu in Svetu lahko pravočasno predložila kakršne koli potrebne predloge.“
‘Article 11b
„Člen 11b
The Commission, in collaboration with the Member States, shall set up an information and awareness campaign on the complete ban on the use of oestradiol 17β in food-producing animals, aimed at farmers and veterinary organisations in the EU as well as the relevant organisations outside the EU which are directly or indirectly involved in the export to the EU of food of animal origin falling within the scope of this Directive.’.
Komisija v sodelovanju z državami članicami pripravi kampanjo informiranja in osveščanja o popolni prepovedi estradiola 17β za živali za proizvodnjo živil, namenjeno kmetom in veterinarskim organizacijam znotraj EU in ustreznim organizacijam izven EU, ki so neposredno ali posredno povezane z izvozom hrane živalskega porekla v EU, ki spada na področje uporabe te direktive.“
Annex II shall be replaced by the text appearing in the Annex to this Directive.
Priloga II se nadomesti z besedilom iz Priloge k tej direktivi.
Member States shall bring into force the laws, regulations and administrative provisions necessary to comply with this Directive by 1 January 2009.
Države članice uveljavijo zakone in druge predpise, potrebne za uskladitev s to direktivo, do 1. januarja 2009.
They shall forthwith communicate to the Commission the text of such laws, regulations and administrative provisions together with a table showing the correlation between them and this Directive.
Komisiji nemudoma sporočijo besedila takšnih zakonov in drugih predpisov, skupaj s korelacijsko tabelo med njimi in to direktivo.